Font Size: a A A
Keyword [Structure-activity Relationships]
Result: 101 - 120 | Page: 6 of 7
101. Design And Structure-activity Relationships Of Compounds For Adult Hippocampal Neurogenesis
102. Design,Synthesis And Biological Evaluation Neuroprotection Activtity Of Celastrol Derivatives
103. Design,synthesis And Biological Evaluation Of Novel 4-phenoxyquinoline Derivatives As C-Met Kinase Inhibitors
104. Study On The Structure-Activity Relationship Of ?-Helix Peptide
105. Design,Synthesis And Anti-melanoma Activity Of Derivatives Based On Compound THPN
106. In Vitro Antioxidant Activity Of Natural Products From Microorganism In Special Eco-environment And Their Structure-Activity Relationships
107. Nuclear receptor engineering based on novel structure activity relationships revealed by farnesyl pyrophosphate
108. Molecular mechanisms of touch sensory transduction in Caenorhabditis elegans: Structure/activity relationships of degeneration channels in touch perception in Caenorhabditis elegans
109. Peptoid mimics of helical, cationic antimicrobial peptides: Studies of structure-activity relationships, synergy, and mechanism
110. Structure-activity relationships and thermodynamics of combretastatin A-4 and A-1 derivatives as potential inhibitors of tubulin polymerization
111. Anticancer structure-activity relationships of semi-synthetic analogs of nordihydroguaiaretic acid
112. In silico approaches for studying transporter and receptor structure-activity relationships
113. I. The structure activity relationships and cytotoxic activity of analogs of tryprostatin A and B. Preparation of irreversible inhibitors for studies of mechanism of action. II. Pharmacophore/receptor models for the GABA(A)/Bz receptor subtypes
114. A structure-activity approach to drug action in pharmacology: (A) Structure-activity relationships involved in DT-diaphorase (NQO1) mediated reduction kinetics and mode of action of anticancer bioreductive benzoquinone alkylating agents. (B) Structural c
115. Novel computational chemistry models for exploring the structure-activity relationships of HIV-1 protease substrates and inhibitors (Immune deficiency)
116. Isolation, synthesis, and biological properties of cyclic defensins: Structure-activity relationships and comparison with protegrin PG-1
117. Synthesis of new glutamate receptor probes: I. Total synthesis of dysiherbaine, a potent glutamate receptor excitotoxin; II. Design and synthesis of dysiherbaine analogues; III. Synthesis and structure-activity relationships of substituted benzothiadiazi
118. Flavonolignan and flavone inhibitors of a Staphylococcus aureus multidrug resistance (MDR) efflux pump: Synthesis and structure activity relationships
119. Computer-aided development of quantitative structure-activity relationships and analysis of data from an artificial nose
120. Structure activity relationships of topoisomerase inhibitors
  <<First  <Prev  Next>  Last>>  Jump to